Multiple Myeloma in Cameroon: Clinico-Biological Characteristics of Patients; an Experience from Douala General Hospital
Journal Title: Haematology International Journal - Year 2018, Vol 2, Issue 1
Abstract
1.1. Background: Multiple myeloma is the most common haematological malignancy among blacks. There is paucity of data on this subject in Africa in general and Cameroon in Cameroon. This study aims at describing initial clinical and basic laboratory features of multiple myeloma in Douala general hospital. 1.2. Methods: This was a retrospective cross sectional review of the medical records of all patients diagnosed with multiple myeloma in Douala general hospital between 2007 and 2013. 1.3. Results: A total of 62 patients were included in the study with an annual rate of 10-11 cases per annum. There was a female predominance with a male female sex ratio of 0.6:1 and a mean age of57.6±12.2 years. Clinical features at presentation were low back pain (72.6%), and anemia (70.9%), while neurologic impairment and nephropathy were found in 66.2% and 17.5% of the patients respectively. Most (63%) of the patients were diagnosed at stage three of the disease at presented with already established complications. 1.4. Conclusion: Multiple myeloma is more common in our context than described in literature presenting in the 5th and 6th decades of life. Most patients present late with already established complications.
Authors and Affiliations
Ngouadjeu Dongho Tsakeu Eveline
Keywords
Related Articles
- EP ID EP291044
- DOI -
- Views 86
- Downloads 0
Fatal Case of Haemophagocytic Syndrome Associated With Infection of Plasmodium Falciparum
Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition which can occur as a primary syndrome (genetic in origin) or arise secondary to infectious, rheumatologic, malignant or metabolic disorders. HLH...
Incidental Detection of Sickle Cell Anaemia as a Significant Haematological Problem in an Island Based Population
1.1. Introduction: Sickle cell anaemia is a haematological disease with a known gentic cause. However, there is paucity of data regarding this condition from islands of the world. Also there is no previous study in which...
Cost-Effectiveness of Idelalisib-Rituximab for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
1.1. Background: A significant survival prolongation was recently reported by adding idelalisib to rituximab (IR) compared with rituximab (R) in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL). No...
Differential Correlation between Foetal Haemoglobin and Full Blood Count Based on Inherited Haemoglobin Type; A Cross-Sectional Study in Cape Coast, Ghana
1.1. Background: Foetal haemoglobin (Hb F) has been shown to modulate the severity of sickle cell anaemia (SCA). However, there is scarcity of data on the impact of Hb F levels in other inherited haemoglobin variants. Th...
Cladribine an Alternative for Midostaurine in FLT3 Positive Acute Myeloid Leukemia
Midostaurinis registered for the indication newly diagnosed acute myeloid leukemia that is FLT3 mutation positive in combination with standard cytarabine and daunorubicine induction and cytarabine consolidation. The regi...